INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106547, 4188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106548, 4188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106549, 4188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106550, 4188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106551, 4188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106552, 4188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106553, 4188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106554, 4190, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c6d8f316ec3300c45f79c82077033142d7a898edd820c8c44db84253220e9a0c9e923ab09b274e0c08fc747fc6f95e92dc82a24ade7c20983551c5852593381273463996034ade00b0ba064a86b52c702a7d5c407c84dd03627710ebe7547e7d063ae087925087d626a4d3f63f9c3427f39715c877e902919a1530659c398247a7ce1c0bafd3eb9dab9df3d9c537b61ca12e4c1d2ec4fdf1e7e66320276c0e2da345ba987dcd817d0b18554190748b3a97082c21732c8ec1bf68a17ce42d757deab3578a4e04aff78134a22dbef0eefc7dde1a3cd679bafe31d275985bc', NULL, X'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', X'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', NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106555, 4190, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'Hybrid', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (106556, 4192, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159687, 1768159687, NULL, NULL, NULL, NULL, NULL, NULL, NULL);